Can Mounjaro Cause Anaemia — and Should You Be Concerned?

Why someone asking this question is making a sensible call

It is a reasonable thing to wonder about. Mounjaro works partly by reducing appetite and slowing the rate at which food moves through the stomach. For most people, that means eating noticeably less. Eating less is the point — but it also raises a practical question: if your overall intake falls, are you still getting enough iron, vitamin B12 and folate, the three nutrients whose shortfall most commonly tips someone into nutritional anaemia?

This is not a dramatic risk unique to tirzepatide. It applies to any sustained period of significantly reduced calorie intake, including other weight-loss approaches. The honest answer is that Mounjaro's trial programme, which enrolled thousands of adults across the SURMOUNT studies, did not flag anaemia as a treatment-related concern. The medicine's UK prescribing information lists its recognised side effects and anaemia does not appear among them. So the direct risk is, based on current evidence, low.

The indirect picture is a little more nuanced, and that is where the decision-making for your own situation begins. If you want a broader overview of what conditions have and have not been linked to tirzepatide use, the full look at what Mounjaro can cause covers the wider landscape.

Nutritional gaps: the more realistic concern on an appetite-suppressing medicine

When appetite falls sharply, people tend to eat less red meat, fewer legumes, smaller portions of leafy vegetables. Those happen to be the foods richest in iron and folate. If that pattern continues for several months, blood levels can drift downward, regardless of which medicine caused the appetite change.

Vitamin B12 is a separate consideration. Tirzepatide slows gastric emptying, and there is some theoretical basis for wondering whether altered gastric conditions might affect B12 absorption over time, since the stomach's acid and intrinsic factor are involved in releasing B12 from food. The clinical evidence on this specific point in tirzepatide users is not yet large enough to draw firm conclusions, and the NHS tirzepatide patient information does not currently list B12 depletion as a known effect. What is clear is that protein and micronutrient adequacy matters more, not less, when overall food volume drops. Staying hydrated, prioritising nutrient-dense foods and keeping an eye on how you feel are practical habits worth building from the start. There is more on the gastrointestinal side of treatment, including why appetite can feel very different in the early weeks, on the page about stomach sounds and digestive changes on Mounjaro.

A blood test before or shortly after starting treatment gives you a useful baseline. Your GP can check full blood count, iron stores, B12 and folate in a single panel. If you are already borderline low in any of these, tell your prescriber at the outset.

Who should think about this more carefully before starting

For most adults starting Mounjaro, anaemia is not a front-of-mind concern. But a few groups have good reason to consider it alongside other eligibility questions.

People with a history of iron-deficiency anaemia, pernicious anaemia or B12 deficiency should flag this clearly during their consultation. Those who follow a vegan or vegetarian diet and already restrict red meat may have a narrower nutritional margin. People with inflammatory bowel conditions affecting absorption are another group for whom a baseline blood check before starting makes particular sense. Conditions such as IBS and gut sensitivity are sometimes present alongside the kind of obesity for which Mounjaro is prescribed, and gut health can influence nutrient uptake independently of the medicine.

Tirzepatide is licensed for adults with a BMI of 30 or above, or 27 and above when a weight-related condition is also present. Lower BMI thresholds apply for some ethnic backgrounds under UK guidance. A prescriber assesses the complete picture, including any blood conditions, before treatment is approved. That assessment is the right place for this conversation. The Mounjaro treatment overview covers the full eligibility criteria if you want to read them before consulting.

Staying on top of blood health during treatment

The most practical step is routine monitoring. If you are on Mounjaro for several months, a periodic blood test (perhaps at the six-month mark, or sooner if you notice unusual fatigue, breathlessness or paleness) lets you catch any downward trend early. Fatigue in the first few weeks of treatment is common for unrelated reasons, so it is worth distinguishing between the tiredness that often accompanies appetite change and the deeper, persistent exhaustion that can signal a blood issue.

Eating adequate protein (at least 60–80 g per day is a common starting point, though individual targets vary) and choosing iron-rich foods such as dark leafy greens, lentils, eggs and fortified cereals helps protect against the nutritional gaps that reduced appetite can create. Keep your prescriber's clinical team informed if your diet has changed substantially or if you have had previous blood results flagged as low.

If you are weighing up what Mounjaro treatment looks like in practice, including the consultation process and what monitoring is involved, the weight-loss treatment page is the clearest starting point. And if you have read something about Mounjaro and neurological concerns, the separate question of Mounjaro and MS is addressed in its own dedicated page. For questions about other less-discussed effects, the Mounjaro and UTI page covers urinary symptoms in detail.

For a deeper look specifically at the research around tirzepatide and iron metabolism, the full evidence review on Mounjaro and anaemia sets out what the data currently shows and where the evidence gaps remain. Pricing and cost considerations, if those are also on your mind, are covered on the Mounjaro price comparison page.

If you have existing blood conditions and want a clinician to review whether Mounjaro is appropriate for you, start your free consultation and our prescribers will assess the full picture.